Bill Snyder Archive — Page 78 of 120
-
January 19, 2017
COX-2 ‘conjugate’ may slow growth of some tumors: study
More than a decade after the anti-inflammatory drugs Vioxx and Bextra were pulled from the market because of a heightened risk of heart attack and stroke in some patients, COX-2 inhibitors may be on the verge of a comeback, this time as anti-cancer agents. -
January 19, 2017
GRE may be poor predictor of science success: study
Since it was created in 1949, the Graduate Record Exam (GRE) has been one of the most widely used requirements for admission to U.S. graduate schools. As a predictor of performance and success in graduate school, however, the exam is not without its critics. -
January 19, 2017
Amount of daylight may impact serotonin programming
The duration of exposure to daylight, or the “photoperiod,” may affect development of seasonal affective disorder by programming serotonin neurons in the brain, according to Vanderbilt University researchers. -
January 17, 2017
A heart-brain connection
Cognitive and attention deficits observed in children following surgery before age 5 to repair congenital heart defects likely will persist into their teens and young adulthood. -
January 12, 2017
Lindsley’s drug discovery efforts land ASPET Award
Craig Lindsley, Ph.D., a leader of Vanderbilt University School of Medicine’s groundbreaking drug discovery program, is the 2017 recipient of the Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET). -
January 12, 2017
Team’s discovery offers new insight on lung cancer risk
Researchers in the Schools of Medicine and Engineering at Vanderbilt University have discovered a proteomic “signature” from the airways of heavy smokers that could lead to better risk assessment and perhaps new ways to stop lung cancer before it starts.